What Researchers Did
Researchers investigated if hyperbaric oxygen therapy could help patients suffering from bleeding and inflammation in the bladder caused by radiation treatment for pelvic cancers.
What They Found
In this study of ten patients, hyperbaric oxygen therapy led to the subsidence of hematuria and improvement in subjective symptoms like urinary frequency in seven patients. All ten patients experienced subjective and objective palliation, and cystoscopic findings such as mucosal oedema and redness also showed partial improvement.
What This Means for Canadian Patients
For Canadian patients experiencing refractory hemorrhagic cystitis after pelvic radiation therapy, this study suggests that hyperbaric oxygen therapy could offer a non-invasive treatment option to alleviate severe symptoms like bleeding and frequent urination. This may improve quality of life for individuals struggling with this challenging complication of cancer treatment.
Canadian Relevance
While this study was conducted in Japan, radiation-induced hemorrhagic cystitis is a severe complication experienced by patients globally, including in Canada. Hyperbaric oxygen therapy for radiation-induced soft tissue necrosis, which includes conditions like hemorrhagic cystitis, is a Health Canada-recognised indication.
Study Limitations
This study was limited by its small sample size of ten patients and its observational, non-randomised design.